Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
34.36
+1.90 (5.85%)
At close: Oct 2, 2026, 4:00 PM EDT
34.56
+0.20 (0.58%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Alamar Biosciences Revenue
Alamar Biosciences had revenue of $29.43M in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $100.42M. In the year 2025, Alamar Biosciences had annual revenue of $74.21M with 195.17% growth.
Revenue (ttm)
$100.42M
Revenue Growth
+195.17%
P/S Ratio
23.74
Revenue / Employee
$351,119
Employees
286
Market Cap
2.38B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 74.21M | 49.07M | 195.17% |
| Dec 31, 2024 | 25.14M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
ALMR News
- 9 days ago - Lancet study using Alamar’s technology reveals divergent responses to Alzheimers - TheFly
- 9 days ago - Lancet Neurology Study Using Alamar Biosciences' Technology Reveals Divergent Biological Responses to Alzheimer's Treatment - GlobeNewsWire
- 15 days ago - Alamar Biosciences rises 15.1% - TheFly
- 15 days ago - Alamar Biosciences rises 9.4% - TheFly
- 18 days ago - Alamar Biosciences Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 4 weeks ago - Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Alamar Biosciences price target raised to $31 from $30 at BofA - TheFly
- 7 weeks ago - Alamar Biosciences price target raised to $32 from $28 at Stifel - TheFly